title: Flying without a net in MDS.
abstract: In this issue of Blood, Malcovati et al discuss the findings of an expert panel of the European LeukemiaNet (ELN) and their recommendations for treating myelodysplastic syndromes (MDS).
authors.affiliation: CLEVELAND CLINIC TAUSSIG CANCER INSTITUTE.
authors.forename: Mikkael A
authors.initials: MA
authors.lastname: Sekeres
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000175:diagnosis* / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents